I think it would be helpful if there was some kind of acknowledgement that these are people that are living with a disease, and they've taken a treatment for that disease, and there is no shame in that they're improving their overall health. Evers said people need to move away from calling GLP-1 drugs weight-loss medications and instead call them obesity medications, which gives them an accurate medical context
When these levels drop, your body may struggle to maintain its natural balance
What the FDA Is Doing and What Changes for Patients Tirzepatide came off the FDA shortage list in December 2024 and semaglutide in February 2025, which removed the legal basis for compounding copies of the approved drugs
On-The-Go Sticks: Individually packaged, making it super easy to carry and supplement daily
These contain actual GLP-1 receptor agonists, not the supplement ingredients found in Peaka GLP-1
Maybe I'll ramp it up to four